查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594055

男性健康诊断市场：按产品类型、适应症、最终用户划分 - 全球预测 2025-2030 年

Mens Health Diagnostics Market by Product (Blood Test, Electrocardiogram, MRI of the Prostate), Type or Indication (Colorectal Cancer, Erectile Dysfunction, Prostate Cancer), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

男性健康诊断市场2023年估值为131.7亿美元，预计到2024年将达到145.9亿美元，复合年增长率为11.31%，到2030年将达到278.9亿美元。

男性健康诊断市场包括各种诊断工具和服务，旨在识别、监测和管理男性族群中常见的常见健康问题，例如心血管疾病、摄护腺癌、低睪固酮和糖尿病。这些诊断解决方案包括先进的影像技术、生物标记测试、基因筛检、实验室测试、照护现场诊断等。随着人们对男性健康问题的认识不断提高，这些诊断对于预防医学和精确治疗方法至关重要。它们的应用范围涵盖医院、诊断中心、诊所和家庭，对于实现定期监测和早期检测、改善患者治疗效果至关重要。这个市场主要由男性特有疾病的增加、健康意识的提高、技术进步和创新的诊断方法所推动。最近的趋势包括人工智慧和诊断工具的整合以提高诊断准确性、开发非侵入性测试方法以及满足个人需求的个人化医疗解决方案。此外，在数位医疗采用增加的推动下，远端医疗和远距离诊断代表了大幅成长的途径。然而，新兴市场面临诊断测试成本上升、意识缺乏以及医疗基础设施不发达等挑战，可能会阻碍市场扩张。围绕诊断测试的严格法规和报销问题也是主要障碍。创新机会在于开发具有成本效益的诊断解决方案，提高测试方法的准确性和可近性，以及促进高科技公司和医疗保健提供者之间的伙伴关係。调查可能会集中在发现生物标记、基于人工智慧的诊断和加强远端医疗技术上。男性健康诊断市场正在动态发展，重点是精准医疗和早期检测，这推动了对促进男性健康整体方法的技术和服务的策略性投资的需求。专注于可及性、效率和个人化护理的公司将在这个不断变化的市场环境中获得丰厚的回报。

主要市场统计
基准年[2023] 131.7亿美元
预测年份 [2024] 145.9亿美元
预测年份 [2030] 278.9亿美元
复合年增长率（%） 11.31%

市场动态：快速发展的男性健康诊断市场的关键市场洞察

供需的动态交互作用正在改变男性健康诊断市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 不健康的饮食习惯和吸烟人数的增加
    • 与文明病增加
    • 全球诊断中心数量增加
  • 市场限制因素
    • 医疗服务分布不均衡
    • 有限的保险范围和监管合规性
  • 市场机会
    • 政府积极努力加强医疗体系
    • 将物联网和人工智慧等创新技术整合到诊断中
  • 市场挑战
    • 缺乏技术精湛、经验丰富的人才

波特五力：驾驭男性健康诊断市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解男性健康诊断市场的外部影响

外部宏观环境因素在塑造男性健康诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解男性健康诊断市场的竞争状况

对男性健康诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在男性健康诊断市场的绩效评估

FPNV 定位矩阵是评估男性健康诊断市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了男性健康诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对男性健康诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 不健康的饮食习惯和吸烟人数的增加
      • 与文明病发生率增加
      • 世界各地诊断中心的数量正在增加
    • 抑制因素
      • 卫生服务分配不均
      • 有限的保险范围和监管合规性
    • 机会
      • 政府加强医疗保健系统的有利倡议
      • 将物联网和人工智慧等创新技术整合到诊断中
    • 任务
      • 缺乏熟练且经验丰富的劳动力
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章男性健康诊断市场：副产品

  • 验血
  • 心电图
  • 前列腺 MRI
  • 睪固酮水平测试
  • 超音波检查
  • 超音波引导前列腺切片检查
  • 造影检查
  • 尿液检查
  • X射线

第七章按类型或适应症分類的男性健康诊断市场

  • 大肠直肠癌
  • 勃起功能障碍
  • 摄护腺癌
  • 睪丸癌

第八章男性健康诊断市场：依最终用户分类

  • 诊断实验室
  • 医院及门诊手术中心
  • 研究/学术机构

第九章 北美和南美男性健康诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区男性健康诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的男性健康诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Access Pharmaceuticals, Inc.
  • ADVANZ PHARMA Corp Limited
  • Beckman Coulter, Inc.
  • Bruker Corporation
  • Cardinal Health Inc.
  • Ecotown Diagnostics Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Future Diagnostics Solutions BV
  • Medical Diagnosis
  • Neuberg Diagnostics
  • Nuance Communications, Inc.
  • Pathnostics
  • PERSOWN, INC.
  • Quest Diagnostics Incorporated
  • SEKISUI DIAGNOSTICS, LLC
Product Code: MRR-431388EE3BC2

The Mens Health Diagnostics Market was valued at USD 13.17 billion in 2023, expected to reach USD 14.59 billion in 2024, and is projected to grow at a CAGR of 11.31%, to USD 27.89 billion by 2030.

The men's health diagnostics market entails various diagnostic tools and services aimed at identifying, monitoring, and managing common health issues prevalent among male populations, such as cardiovascular diseases, prostate cancer, low testosterone, diabetes, and other conditions. These diagnostic solutions encompass advanced imaging techniques, biomarker tests, genetic screening, lab tests, and point-of-care diagnostics. As awareness of men's health issues grows, these diagnostics are essential for preventive health care and accurate treatment approaches. Their application spans hospitals, diagnostic centers, clinics, and home settings, enabling regular monitoring and early detection, which are crucial for improving patient outcomes. The market is predominantly driven by increasing incidences of male-specific diseases, rising health consciousness, advancements in technology, and innovative diagnostic methods. Recent opportunities rest in integrating AI with diagnostic tools for enhanced accuracy, the development of non-invasive testing methods, and personalized healthcare solutions to cater to individual needs. Additionally, telemedicine and remote diagnostics present substantial growth avenues, driven by increased digital health adoption. However, the market faces challenges, including high costs of diagnostic tests, lack of awareness, and inadequate healthcare infrastructure in developing regions, which might hinder market expansion. Stringent regulations related to diagnostic tests and reimbursement issues also pose significant obstacles. Innovation opportunities lie in developing cost-effective diagnostic solutions, improving the accuracy and accessibility of testing methods, and fostering partnerships between tech companies and healthcare providers. Research could focus on biomarker discovery, AI-driven diagnostics, and enhancing telehealth technologies. The men's health diagnostics market is dynamic and evolving, with an emphasis on precision medicine and early detection, emphasizing the need for strategic investments in technology and services that promote a holistic approach to men's health. Companies focusing on accessibility, efficiency, and personalized care stand to reap significant rewards in this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 13.17 billion
Estimated Year [2024] USD 14.59 billion
Forecast Year [2030] USD 27.89 billion
CAGR (%) 11.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mens Health Diagnostics Market

The Mens Health Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Unhealthy eating habits and growing prevalence of smoking population
    • Increased incidence of lifestyle disease
    • Rise in number of diagnostic centers all over the globe
  • Market Restraints
    • Uneven distribution of medical services
    • Limited insurance coverage and regulatory compliance
  • Market Opportunities
    • Favorable government initiatives to strengthen healthcare system
    • Integration of innovative technologies such as IoT and AI in diagnostic
  • Market Challenges
    • Shortage of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Mens Health Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mens Health Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mens Health Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mens Health Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mens Health Diagnostics Market

A detailed market share analysis in the Mens Health Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mens Health Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mens Health Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mens Health Diagnostics Market

A strategic analysis of the Mens Health Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mens Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Access Pharmaceuticals, Inc., ADVANZ PHARMA Corp Limited, Beckman Coulter, Inc., Bruker Corporation, Cardinal Health Inc., Ecotown Diagnostics Pvt. Ltd., F. Hoffmann-La Roche Ltd., Future Diagnostics Solutions B.V., Medical Diagnosis, Neuberg Diagnostics, Nuance Communications, Inc., Pathnostics, PERSOWN, INC., Quest Diagnostics Incorporated, and SEKISUI DIAGNOSTICS, LLC.

Market Segmentation & Coverage

This research report categorizes the Mens Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Test, Electrocardiogram, MRI of the Prostate, Testosterone Levels Test, Ultrasound Test, Ultrasound-Guided Prostate Biopsy, Urethrogram, Urine Tests, and X-Ray.
  • Based on Type or Indication, market is studied across Colorectal Cancer, Erectile Dysfunction, Prostate Cancer, and Testicular cancer.
  • Based on End-user, market is studied across Diagnostic Laboratories, Hospitals & Ambulatory Surgery Center, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Unhealthy eating habits and growing prevalence of smoking population
      • 5.1.1.2. Increased incidence of lifestyle disease
      • 5.1.1.3. Rise in number of diagnostic centers all over the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Uneven distribution of medical services
      • 5.1.2.2. Limited insurance coverage and regulatory compliance
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives to strengthen healthcare system
      • 5.1.3.2. Integration of innovative technologies such as IoT and AI in diagnostic
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled and experienced workforce
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mens Health Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Test
  • 6.3. Electrocardiogram
  • 6.4. MRI of the Prostate
  • 6.5. Testosterone Levels Test
  • 6.6. Ultrasound Test
  • 6.7. Ultrasound-Guided Prostate Biopsy
  • 6.8. Urethrogram
  • 6.9. Urine Tests
  • 6.10. X-Ray

7. Mens Health Diagnostics Market, by Type or Indication

  • 7.1. Introduction
  • 7.2. Colorectal Cancer
  • 7.3. Erectile Dysfunction
  • 7.4. Prostate Cancer
  • 7.5. Testicular cancer

8. Mens Health Diagnostics Market, by End-user

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Ambulatory Surgery Center
  • 8.4. Research & Academic Institutes

9. Americas Mens Health Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Mens Health Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Mens Health Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Access Pharmaceuticals, Inc.
  • 2. ADVANZ PHARMA Corp Limited
  • 3. Beckman Coulter, Inc.
  • 4. Bruker Corporation
  • 5. Cardinal Health Inc.
  • 6. Ecotown Diagnostics Pvt. Ltd.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Future Diagnostics Solutions B.V.
  • 9. Medical Diagnosis
  • 10. Neuberg Diagnostics
  • 11. Nuance Communications, Inc.
  • 12. Pathnostics
  • 13. PERSOWN, INC.
  • 14. Quest Diagnostics Incorporated
  • 15. SEKISUI DIAGNOSTICS, LLC

LIST OF FIGURES

  • FIGURE 1. MENS HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. MENS HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MENS HEALTH DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023